~ AlphaMD Lets be real: starting testosterone replacement therapy (TRT) is a big step and when its done right, it can be life-changing
O impacto financeiro to forte que a pesquisa da PwC indicou que 45% dos pacientes interrompem o uso dos medicamentos justamente por conta do seu alto custo
At Cape Fear Physical Medicine and Rehab, we address these concerns with a holistic approach
Based on current phase 3 TRIUMPH trial timelines, a regulatory submission to the MHRA is not anticipated before 20262027 at the earliest, with a possible marketing authorisation in 20272028 and NHS availability potentially from 2028 onwards, subject to NICE appraisal
Continuous administration of human corticotropin-releasing hormone in the absence of glucocorticoid feedback in man
Pharmaceuticals, 18 (8), 1097